UIC
VASC

Uniplan Investment Counsel’s Vascular Solutions Inc VASC Stock Holding History

Uniplan Investment Counsel’s Portfolio VASC Stock Details VASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-130,953
Closed -$7.35M – 108
2016
Q4 		$7.35M Buy
130,953
+2,771
+2% +$141K 0.33% 71
2016
Q3 		$6.18M Buy
128,182
+5,362
+4% +$250K 0.28% 71
2016
Q2 		$5.12M Buy
122,820
+5,391
+5% +$201K 0.23% 83
2016
Q1 		$3.82M Buy
117,429
+422
+0.4% +$12.2K 0.19% 94
2015
Q4 		$4.02M Buy
117,007
+4,809
+4% +$163K 0.2% 94
2015
Q3 		$3.64M Sell
112,198
-107,488
-49% -$3.85M 0.18% 94
2015
Q2 		$7.63M Buy
+219,686
New +$7.16M 0.35% 70

Other funds holding VASC

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Uniplan Investment Counsel's VASC Position: Q1 2017 in Review

Uniplan Investment Counsel sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 130,953 shares — an estimated $7.35M sold.

Uniplan Investment Counsel first reported a position in VASC in Q2 2015 and held it in 7 quarters. The position peaked at $7.63M in Q2 2015. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • Uniplan Investment Counsel reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • Uniplan Investment Counsel sold 130,953 Vascular Solutions Inc shares in Q1 2017, an estimated $7.35M.
  • Uniplan Investment Counsel first reported a position in Vascular Solutions Inc in Q2 2015 and held it in 7 quarters.
  • Uniplan Investment Counsel's Vascular Solutions Inc position peaked at $7.63M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Uniplan Investment Counsel's 13F filing for Q1 2017, filed 12 May 2017.